Falcon Real World Evidence Registry
- Conditions
- Cancer
- Interventions
- Device: Exact Sciences Multicancer Early Detection (MCED) Test
- Registration Number
- NCT06589310
- Lead Sponsor
- Exact Sciences Corporation
- Brief Summary
This is a multi-site registry of patients receiving the Exact Sciences Multicancer Early Detection (MCED) test.
- Detailed Description
This study was designed to simulate a real-world application of Exact Science's Multicancer Early Detection (MCED) test. Participants will be offered the Exact Science's MCED test annually for 3 years. If at any point during those 3 years a participant is diagnosed with cancer, they will become ineligible for further testing. Data will be collected for 5 years following the baseline test.
There will be two data collection approaches as part of this study. The first will be collection of self-report data related to the testing experience. The second will be periodic and largely automated extraction of pre-specified data elements from existing electronic data sources. A comparison data set will be constructed from records of individuals who did not receive the MCED test.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 25000
- Participant age at time of consent is between 50 and 80 years
- Agree to receive the Exact Sciences MCED test and follow-up imaging
- Willing and able to provide informed consent
- Access to a suitable technology and willing to complete surveys electronically
- Any invasive tumor (excluding non-melanoma skin cancers) or hematological malignancy in the previous three years or current suspicion of cancer and/or in active treatment (e.g., chemotherapy, radiation therapy, immunotherapy, and/or surgery
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Multicancer Early Detection (MCED) cohort Exact Sciences Multicancer Early Detection (MCED) Test -
- Primary Outcome Measures
Name Time Method Vital status Up to 5 years Particpant is alive or deceased
Cancer status Up to 5 years Presence or absence of cancer
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (2)
Endeavor Health
🇺🇸Evanston, Illinois, United States
Baylor Scott & White Health
🇺🇸Dallas, Texas, United States